A continuous-flow left ventricular assist device successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours.
Case Report (n=1)
No
Does a continuous-flow LVAD provide hemodynamic support during sustained ventricular fibrillation in patients with end-stage heart failure?
Continuous-flow LVADs can maintain hemodynamics and be lifesaving during prolonged sustained ventricular fibrillation.
Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation.
Sims et al. (Thu,) conducted a case report in Sustained ventricular fibrillation in end-stage heart failure (n=1). Continuous-flow left ventricular assist device (LVAD) was evaluated on Hemodynamic support during sustained ventricular fibrillation. A continuous-flow left ventricular assist device successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours.